IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | +111.4% | 15,391 | +132.8% | 0.00% | – |
| Q2 2023 | $70 | +6900.0% | 6,612 | +5966.1% | 0.00% | – |
| Q1 2023 | $1 | -99.3% | 109 | -99.0% | 0.00% | – |
| Q4 2022 | $134 | -99.9% | 10,888 | -0.1% | 0.00% | – |
| Q2 2022 | $125,000 | +60.3% | 10,900 | +73.8% | 0.00% | – |
| Q1 2022 | $78,000 | +52.9% | 6,270 | +59.9% | 0.00% | – |
| Q3 2021 | $51,000 | -94.2% | 3,921 | -94.9% | 0.00% | -100.0% |
| Q4 2020 | $878,000 | +136.0% | 77,200 | +86.6% | 0.00% | 0.0% |
| Q3 2020 | $372,000 | +332.6% | 41,379 | +384.8% | 0.00% | – |
| Q1 2020 | $86,000 | +83.0% | 8,536 | +138.8% | 0.00% | – |
| Q4 2019 | $47,000 | +291.7% | 3,574 | +142.6% | 0.00% | – |
| Q3 2019 | $12,000 | – | 1,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |